Switzerland buys 7 million doses of Moderna's COVID-19 booster

Shares of Moderna Inc. MRNA, -1.97% were down 2.4% in trading on Monday after the company said Switzerland exercised an option to buy an additional seven million doses of its COVID-19 booster. Moderna said delivery of those shots is set to occur in the second half of 2022. Switzerland has ordered a total of 27.5 million doses from Moderna. The company’s stock is up 134.1% this year, while the broader S&P 500 SPX, +0.07% has gained 25.8%.